Danhong Chen

机构：Sun Yat-sen University, South China Normal University

发表论文 9 篇 · 总被引 134 次 · h-index 4

代表论文

• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 80)
• Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy (2023 · Science China Life Sciences · 被引 35)
• Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy (2025 · Nano Letters · 被引 9)
• Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy (2026 · Cell Reports Medicine · 被引 4)
• An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapy (2025 · Journal of Controlled Release · 被引 4)
• An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy (2026 · Journal of the American Chemical Society · 被引 2)